Aberforth Smaller Companies Trust appoints Roy Davis as non-executive director, audit committee member

By Public Technologies
  • Aberforth Smaller Companies Trust appointed Roy Davis as independent non-executive director, effective Oct. 21, 2026.
  • Davis also joins the audit committee on the same date.
  • He is non-executive chair of Inspiration Healthcare Group, Surgical Innovations Group, Galton Group; former chair of Medica Group.
  • Executive background includes CEO roles at Optos, Gyrus Group; former vice president at Arthur D. Little.
  • Davis will step down as a non-executive director at Futura Medical on Oct. 20, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aberforth Smaller Companies Trust plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609291147PR_NEWS_PRUKDSCX_0097) on September 29, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.